Alec Machiels - Net Worth and Insider Trading

Alec Machiels Net Worth

The estimated net worth of Alec Machiels is at least $22 Million dollars as of 2024-11-06. Alec Machiels is the Director of Apellis Pharmaceuticals Inc and owns about 779,370 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $22 Million. Details can be seen in Alec Machiels's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alec Machiels has not made any transactions after 2023-11-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Alec Machiels

Alec Machiels Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alec Machiels owns 3 companies in total, including Apellis Pharmaceuticals Inc (APLS) , Creative Realities Inc (CREX) , and Neo Performance Materials (MCPIQ) .

Click here to see the complete history of Alec Machiels’s form 4 insider trades.

Insider Ownership Summary of Alec Machiels

Ticker	Comapny	Transaction Date	Type of Owner
APLS	Apellis Pharmaceuticals Inc	2023-11-17	director
CREX	Creative Realities Inc	2019-07-01	director
MCPIQ	Neo Performance Materials	2010-07-29	director

Alec Machiels Latest Holdings Summary

Alec Machiels currently owns a total of 1 stock. Alec Machiels owns 779,370 shares of Apellis Pharmaceuticals Inc (APLS) as of November 17, 2023, with a value of $22 Million.

Latest Holdings of Alec Machiels

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
APLS	Apellis Pharmaceuticals Inc	2023-11-17	779,370	28.08	21,880,813

Holding Weightings of Alec Machiels

Alec Machiels Form 4 Trading Tracker

According to the SEC Form 4 filings, Alec Machiels has made a total of 41 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 0 buys and 41 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the sale of 1,250 shares on November 17, 2023, which brought Alec Machiels around $59,675.

Insider Trading History of Alec Machiels

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alec Machiels Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Alec Machiels Ownership Network

Ownership Network List of Alec Machiels

No Data

Ownership Network Relation of Alec Machiels

Alec Machiels Owned Company Details

What does Apellis Pharmaceuticals Inc do?

Who are the key executives at Apellis Pharmaceuticals Inc?

Alec Machiels is the director of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks James George Chopas , Chief Operating Officer Pascal Deschatelets , and Chief Financial Officer Timothy Eugene Sullivan .

Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary

Over the past 18 months, Alec Machiels made 7 insider transaction in Apellis Pharmaceuticals Inc (APLS) with a net sale of 8,750. Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 308,688 shares made by Pascal Deschatelets , a net sale of 463,087 shares made by Cedric Francois , and a net sale of 102,839 shares made by Timothy Eugene Sullivan .

In summary, during the past 3 months, insiders sold 37,742 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 37,742 shares. During the past 18 months, 1,275,451 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,275,451 shares.

Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Apellis Pharmaceuticals Inc Insider Transactions

No Available Data

What does Creative Realities Inc do?

Who are the key executives at Creative Realities Inc?

Alec Machiels is the director of Creative Realities Inc. Other key executives at Creative Realities Inc include director & 10 percent owner & Chief Executive Officer Richard C Mills , CFO Logan William Lindsey Iv , and 10 percent owner Slipstream Funding, Llc .

Creative Realities Inc (CREX) Insider Trades Summary

Over the past 18 months, Alec Machiels made no insider transaction in Creative Realities Inc (CREX). Other recent insider transactions involving Creative Realities Inc (CREX) include a net sale of 3,800 shares made by Laurence W Lytton , a net purchase of 50,000 shares made by Richard C Mills , and a net purchase of 12,500 shares made by Logan William Lindsey Iv .

In summary, during the past 3 months, insiders sold 0 shares of Creative Realities Inc (CREX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 14,800 shares of Creative Realities Inc (CREX) were sold and 73,500 shares were bought by its insiders, resulting in a net purchase of 58,700 shares.

Creative Realities Inc (CREX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Creative Realities Inc Insider Transactions

No Available Data

What does Neo Performance Materials do?

Who are the key executives at Neo Performance Materials?

Alec Machiels is the director of Neo Performance Materials. Other key executives at Neo Performance Materials include director & President and CEO Mark A. Smith , EVP and General Counsel Ashburn John F. Jr. , and 10 percent owner Resource Capital Fund V L.p. .

Neo Performance Materials (MCPIQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Neo Performance Materials (MCPIQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neo Performance Materials (MCPIQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neo Performance Materials (MCPIQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neo Performance Materials Insider Transactions

No Available Data

Alec Machiels Mailing Address

Above is the net worth, insider trading, and ownership report for Alec Machiels. You might contact Alec Machiels via mailing address: 505 Park Avenue, 21st Floor, New York Ny 10022.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.